Plexiform neurofibromas in NF1: toward biologic-based therapy.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMID 12041525)

Published in Neurology on May 28, 2002

Authors

R J Packer1, D H Gutmann, A Rubenstein, D Viskochil, R A Zimmerman, G Vezina, J Small, B Korf

Author Affiliations

1: Department of Neurology, Children's National Medical Center, George Washington University, Washington, DC 20010, USA. rpacker@cnmc.org

Articles citing this

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23

How does the Schwann cell lineage form tumors in NF1? Glia (2008) 1.63

Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years. Clin Oral Investig (2007) 1.62

Resection of small plexiform neurofibromas in neurofibromatosis type 1 children. World J Surg Oncol (2005) 1.39

Advances in the treatment of neurofibromatosis-associated tumours. Nat Rev Clin Oncol (2013) 1.26

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Neurology (2009) 1.14

The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice. J Clin Invest (2006) 1.10

Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas. Neurology (2011) 1.08

MR imaging of abdominopelvic involvement in neurofibromatosis type 1: a review of 43 patients. Pediatr Radiol (2004) 1.06

Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging (2010) 1.04

Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma. Am J Pathol (2006) 0.95

The NF1 gene revisited - from bench to bedside. Oncotarget (2014) 0.91

Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med (2013) 0.88

Optimizing biologically targeted clinical trials for neurofibromatosis. Expert Opin Investig Drugs (2013) 0.88

Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. J Pharmacol Exp Ther (2008) 0.83

Plexiform neurofibromatosis involving face and oral cavity. J Oral Maxillofac Pathol (2014) 0.83

Achieving consensus for clinical trials: the REiNS International Collaboration. Neurology (2013) 0.82

Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology (2013) 0.81

Plexiform neurofibroma of the submandibular gland in patient with von Recklinghausen's disease. Rare Tumors (2011) 0.81

Plexiform neurofibroma in the submandibular gland along with small diffuse neurofibroma in the floor of the mouth but without neurofibromatosis-1: a rare case report. Ecancermedicalscience (2013) 0.79

Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone. J Biomed Biotechnol (2004) 0.79

A child with axillary freckling and café au lait spots. CMAJ (2002) 0.79

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro Oncol (2017) 0.77

Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute. Contemp Clin Trials (2010) 0.76

Neurofibromatosis in a 16 Year old. Eplasty (2013) 0.75

Large Cervical Vagus Nerve Tumor in a Patient with Neurofibromatosis Type 1 Treated with Gross Total Resection: Case Report and Review of the Literature. J Brachial Plex Peripher Nerve Inj (2016) 0.75

A silent tumor of the gingiva: An unusual case report and surgical management with 1 year follow-up. J Indian Soc Periodontol (2013) 0.75

Synchronous plexiform neurofibroma in the arytenoids and neurofibroma in the parapharynx in a patient with non-neurofibromatosis: a case report. J Med Case Rep (2013) 0.75

Unexpected diagnosis of superficial neurofibroma in a lesion with imaging features of a vascular malformation. Pediatr Radiol (2005) 0.75

Articles by these authors

Group B streptococcal neonatal and infant infections. J Pediatr (1973) 10.25

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell (1990) 8.10

Mission critical--integrating clinician-educators into academic medical centers. N Engl J Med (1999) 6.41

The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell (1990) 5.24

The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell (1990) 4.84

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42

Recombination during gene transfer into mouse cells can restore the function of deleted genes. Science (1983) 4.32

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65

Nonaccidental head injury in infants--the "shaken-baby syndrome". N Engl J Med (1998) 3.46

Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet (1977) 2.48

Surveillance scanning of children with medulloblastoma. N Engl J Med (1994) 2.47

MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology (1992) 2.39

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

Computed tomography of shearing injuries of the cerebral white matter. Radiology (1978) 2.23

Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation (1998) 2.21

Effect of improved sanitary facilities on infant diarrhea in a Hopi village. Public Health Rep (1969) 2.20

Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13

Intracranial hematomas: imaging by high-field MR. Radiology (1985) 2.08

Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin. Diabetes (1968) 2.07

The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol (1996) 2.05

cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03

Overestimation of copper deficiency in horses? Vet Rec (1995) 2.03

Fusiform dilatations of the carotid artery following radical surgery of childhood craniopharyngiomas. J Neurosurg (1991) 2.01

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology (2009) 2.00

A structurally abnormal insulin causing human diabetes. Nature (1979) 1.99

Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med (1979) 1.88

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86

High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene (2008) 1.84

Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping. Am J Hum Genet (1993) 1.83

Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics (1995) 1.79

Epidemic of pharyngitis due to streptococci of Lancefield group G. Lancet (1969) 1.78

Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. Radiology (1991) 1.78

Ventriculus terminalis of the conus medullaris: MR findings in children. AJNR Am J Neuroradiol (1995) 1.77

INFARCTION OF THE GREATER OMENTUM. Can Med Assoc J (1946) 1.76

Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76

Phenotype characterization and natural history of spondylothoracic dysplasia syndrome: a series of 27 new cases. Am J Med Genet A (2004) 1.75

Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr (2001) 1.71

The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations. Genomics (1990) 1.66

Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry (1997) 1.63

Advances in satellite remote sensing of environmental variables for epidemiological applications. Adv Parasitol (2000) 1.63

Medulloblastoma: clinical and biologic aspects. Neuro Oncol (1999) 1.61

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics (1999) 1.60

Integrating clinician-educators into Academic Medical Centers: challenges and potential solutions. Acad Med (2000) 1.57

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest (2000) 1.56

Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56

Cellular and humoral immune response to group B streptococci. J Pediatr (1973) 1.55

Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene (1997) 1.55

Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. Am J Med Genet (1995) 1.55

Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology (2001) 1.54

Women general practitioners in Oxfordshire. J R Coll Gen Pract (1980) 1.54

Opsonin system of the group B streptococcus. Infect Immun (1974) 1.53

Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol (1996) 1.47

Pathophysiology, treatment and outcome following severe head injury in children. Childs Brain (1979) 1.46

Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45

Cephaloceles and related malformations. AJNR Am J Neuroradiol (1992) 1.44

Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem (1999) 1.43

A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43

Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology (1998) 1.42

Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation. Radiographics (1995) 1.41

Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40

Three mutant insulins in man. Nature (1983) 1.40

Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics (1990) 1.40

Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol (1988) 1.39

The cyclic dilemma: organic, functional, and environmental interaction in a young teenager. J Am Acad Child Adolesc Psychiatry (1995) 1.39

Fostering a new relationship between departments of medicine and teaching hospitals. Acad Med (1993) 1.39

Sudden death in Williams syndrome: report of ten cases. J Pediatr (1996) 1.38

Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology (1990) 1.38

Abnormal magnetic resonance images in hemorrhagic shock and encephalopathy syndrome. J Child Neurol (1992) 1.38

Value of T-agglutination typing of group A streptococci in epidemiologic investigations. Health Lab Sci (1968) 1.38

Tumors of the parapharyngeal space and upper neck: MR imaging characteristics. Radiology (1987) 1.37

Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg (1992) 1.36

Microtiter indirect hemagglutination procedure for identification of streptococcal M-protein antibodies. Appl Microbiol (1968) 1.34

MR diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr (1986) 1.33

Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32

Social support and self-esteem predict changes in bipolar depression but not mania. J Affect Disord (2000) 1.31

Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology (2003) 1.29

Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet (1999) 1.29

Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27

Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet (1996) 1.27

The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes (1986) 1.27

Changes in brain water diffusion during childhood. Neuroradiology (1999) 1.25

Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg (1996) 1.25

Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24

Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci U S A (1985) 1.23

Computed tomography of intracerebral hematomas. I. Transmission CT observations on hematoma resolution. AJR Am J Roentgenol (1977) 1.23

Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol (2007) 1.22

CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology (2007) 1.22

Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am J Roentgenol (1988) 1.22

Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res (1998) 1.21

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol (2001) 1.21

Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol (2006) 1.20

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology (1995) 1.20

A sign of subarachnoid bleeding on cranial computed tomograms of pediatric head trauma patients. Radiology (1978) 1.19

Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg (1991) 1.19

X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Am J Med Genet (1999) 1.18